U.S. market Closed. Opens in 8 hours 57 minutes

CARA | Cara Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue20.97M41.87M23.03M135.08M19.89M13.47M911.00K86.00K3.80M3.18M11.96M1.19MN/A
Cost of Revenue6.17M7.27M1.55M107.07M113.16M75.53M48.52M49.25M21.22M15.07M8.69M1.92MN/A
Gross Profit14.79M34.60M21.47M28.01M-93.28M-62.06M-47.61M-49.17M-17.42M-11.89M3.28M-731.00KN/A
Operating Expenses136.29M122.14M112.11M129.70M131.56M90.85M60.40M58.49M28.99M21.25M12.20M7.43M9.57M
Selling, General & Admin27.65M30.26M29.41M21.75M17.75M15.32M11.87M9.23M7.77M6.18M3.52M2.83M2.41M
Research & Development108.51M91.88M82.70M107.85M113.82M75.53M48.52M49.25M21.22M15.07M8.69M4.60M7.16M
Other Operating ExpensesN/A2.06M642.00K97.00K4.49M2.98M1.16M652.00K101.00K361.00KN/AN/A-180.00K
Operating Income-121.50M-87.53M-89.08M5.38M-111.68M-77.38M-59.48M-58.40M-25.19M-18.07M-237.00K-6.24M-9.57M
Other Expenses / Income2.98M2.06M642.00K2.33M4.49M2.98M1.16M652.00K101.00K126.00K-3.76M-66.00K-275.00K
Before Tax Income-118.51M-85.47M-88.44M7.72M-107.19M-74.40M-58.33M-57.75M-25.09M-17.95M-3.99M-6.30M-9.84M
Income Tax ExpensesN/A-2.06M-248.00K-691.00K-816.00K-389.00K-204.00K-468.00K-397.00K-201.00K-30.00K-31.00K-35.00K
Net Income-118.51M-83.41M-88.19M8.41M-106.37M-74.01M-58.12M-57.28M-24.69M-17.75M-3.96M-6.27M-9.81M
Interest Expenses604.00KN/AN/AN/AN/AN/AN/AN/AN/A126.00K3.76MN/AN/A
Basic Shares Outstanding54.15M53.65M50.72M47.41M42.67M35.89M31.20M27.28M24.62M20.88M21.84M6.18M6.18M
Diluted Shares Outstanding54.15M53.65M50.72M47.92M42.67M35.89M31.20M27.28M24.62M20.97M21.84M6.18M6.18M
EBITDA-117.65M-83.80M-88.19M5.59M-111.48M-77.01M-58.99M-56.94M-24.35M-17.29M552.00K-5.21M-8.58M
EBITDA Margin-561.09%-200.17%-382.98%4.14%-560.60%-571.77%-6,475.30%-66,203.49%-640.26%-544.19%4.61%-438.24%0.00%
EBIT-117.91M-85.47M-88.44M7.72M-107.19M-74.40M-58.33M-57.75M-25.09M-17.82M-237.00K-6.30M-9.84M
EBIT Margin-562.33%-204.16%-384.06%5.71%-539.02%-552.39%-6,402.74%-67,148.84%-659.66%-560.91%-1.98%-529.58%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙